Tivozanib Bests Sorafenib in Metastatic Renal Cell Carcinoma

Progression - free survival longer in those receiving tivozanib as third - or fourth - line therapy
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Nephrology, Oncology, Pharmacy, Journal, Source Type: news